News & Updates
Filter by Specialty:
Lenvatinib-pembrolizumab combo fails to spring forward in HCC treatment
In the phase III LEAP*-002 study, a combination regimen comprising lenvatinib and pembrolizumab appeared to have similar efficacy and safety as lenvatinib monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC).
Lenvatinib-pembrolizumab combo fails to spring forward in HCC treatment
19 Oct 2022
Sugar-sweetened drink intake tied to increased IBD risk
Consumption of sugar-sweetened beverages (SSBs) was associated with increased risk of inflammatory bowel disease (IBD), a large population-based study suggests. This association was not found with artificially sweetened beverages (ASBs) and natural juices.
Sugar-sweetened drink intake tied to increased IBD risk
18 Oct 2022
Anti-TNF continuation after pregnancy prevents relapse in women with IBD
Treatment continuation with antitumour necrosis factor (anti-TNF) after 24 weeks of pregnancy seems to provide benefits in terms of inflammatory bowel disease (IBD) activity and prematurity without affecting neonatal outcomes and serious infections in newborns, reports a study.
Anti-TNF continuation after pregnancy prevents relapse in women with IBD
16 Oct 2022
Sigmoidoscopy screening offers 15-year benefit in CRC incidence, mortality
Sigmoidoscopy screening provides a significant and sustained effect on colorectal cancer (CRC) incidence and mortality for 15 years, according to a pooled analysis of randomized trials.
Sigmoidoscopy screening offers 15-year benefit in CRC incidence, mortality
15 Oct 2022
Pan-enteric capsule endoscopy accurately diagnoses IBD
The use of pan-enteric capsule endoscopy (PCE) leads to high diagnostic yield for inflammatory bowel diseases (IBDs), often even matching that of colonoscopy and magnetic resonance enterography (MRE), reports a recent meta-analysis.
Pan-enteric capsule endoscopy accurately diagnoses IBD
10 Oct 2022
ERAS protocol safe, shortens postoperative stay in elderly gastric cancer patients
Among older adults undergoing gastrectomy for gastric cancer, employing the Enhanced Recovery After Surgery (ERAS) protocol leads to a shorter postoperative hospital stay without introducing new safety signals, a recent study has found.
